Answers are grounded in this paper and cite their sources.
CEDM is a promising technique in the supplemental evaluation of patients with mammographically inconclusive findings and potentially in the screening of women with mammographically dense breasts. CEDM is emerging as a cost-effective alternative to dynamic contrast-enhanced MRI to stage newly diagnosed breast cancer and evaluate response to neoadjuvant chemotherapy.
No takes yet. Share an insight, caveat, or question.
Polat et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: